SAINMHÍNIÚ a type of immunotherapy that attempts to stimulate the patient's own immune system to respond to tumour antigens TAGAIRT Active Specific Immunotherapy: Melanoma Vaccine, in: Medical Policy Manual, 2000, BlueCross BlueShield of Tennessee
NÓTA This vaccine can be prepared in a variety of ways. The vaccine encompasses the removal of tumour cells from the patient's body, modifying them and then reintroducing them into the patient. This vaccine is focused on therapeutic treatment rather than prevention. The use of melanoma vaccine is considered investigational due to a lack of scientific evidence in the medical literature that the vaccine improves net health outcomes.